Anesthesia Intraoral Module
AIM delivers oxygen and captures exhaled carbon dioxide for capnography in patients undergoing clinical procedures and require monitoring, per the safety guidelines of the American Society of Anesthesiologists (ASA).
Disclaimer: AIM is currently undergoing development and has not been approved by the FDA for patient use.
How is AIM used?
AIM is placed between the teeth of the upper and lower jaw. Oxygen and capnography ports on AIM are connected to the oxygen supply line and the capnography monitor.
96% FiO2 Delivery
AIM’s innovative oxygen delivery closer to the tracheal inlet allows FiO2 of 96%. The efficient system uses significantly less oxygen, providing additional value in situations where oxygen conservation is essential (EMT with portable oxygen tanks).
AIM was recently tested by a third-party lab in CA to collect data for FDA 510(k) submission. The sensor at the simulated patient’s trachea recorded 96% FiO2.
Around-the-face capnography by a face mask typically shows small-sized, poor-quality ETCO2 waveforms.
AIM’s capnography port closer to the trachea enables larger, well defined ETCO2 waveform and may help differentiate hypoventilation from artifacts. An early alert may help reduce the risk of impending hypoxia.
Single-Step Oral Airway Placement
Oral airway placement for upper airway obstruction during endoscopy is a six-step process (Remove face mask, remove bite block, pry the jaw open, place oral airway, replace bite block, replace face mask).
With AIM in place, oral airway placement is a single step, minimizing procedural interruptions and delays.
Seamless Conversion to General Anesthesia
Emergent conversion to general anesthesia occurs secondary to excessive patient movement, extreme discomfort, or respiratory failure.
AIM replaces the traditional multi-step and injury-prone maneuvers with seamless conversion to general anesthesia.
EGD and TEE bite-blocks and awake fiber-optic intubation (pink) airways are not needed, saving resources and contaminated medical waste disposal.
May Lower the Risk of Airway Fires
Nasal cannulas and face masks accumulate oxygen around the patient’s face (oxygen is heavier than air), risking airway fires, patient injuries, and lawsuits. AIM’s oxygen delivery into the oro-pharynx may help reduce the risk of airway fires.
Small Size, Big Impact
Despite its small size, AIM’s patient safety features, patient comfort, and portability could make it highly compatible with a wide range of NORA patients.
Lower Environmental Impact
With a compact profile, AIM consumes fewer manufacturing resources.
Additionally, by eliminating the need for EGD, TEE bite-blocks, and awake fiberoptic intubation (pink) airways, AIM further lowers disposables consumption.
Manufactured in the USA
With a focus on manufacturing the highest quality medical device, everything from collaborating on the design, device molds, sourcing raw materials, manufacturing, parts assembly, and packaging is done here in the US. No overseas containers, and no supply chain issues.